Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-041979

Chief Executive Officer returned 551,197 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Anzalone Christopher Richard Chief Executive Officer 2022-07-08 Returned to the company −551,197 3,508,938 D
Loading xslF345X03/doc4.xml…